Natco Pharma USA

Natco Pharma USA (formerly DASH Pharmaceuticals) is the United States subsidiary of Natco Pharma Limited. We’re a pharmaceutical company engaged in developing, manufacturing and marketing generic finished dosage formulations (FDFs) and active pharmaceutical ingredients (APIs). Our specialty is in niche therapeutic areas and producing complex products – with the ultimate goal of increasing access to affordable medicines that meet the highest standards of quality, supply reliability and customer service. We’re a trusted supplier of medicines, as evidenced by our work with some of the world’s largest generic pharmaceutical companies. Natco has co-developed, manufactured, and supplied several first-time generic and complex generic products in the U.S. market, including Lenalidomide Capsules, Oseltamivir Capsules, Lapatinib Tablets, Everolimus Tablets, Glatiramer Acetate Pre-Filled Syringes, and Liposomal Doxorubicin Vials.